Updated:
Sitero
Sitero combines full-service clinical trial delivery with proprietary eClinical technology. EDC, RTSM, CTMS, eTMF, IRB, and drug safety under one partner.
Sitero
Sitero combines full-service clinical trial delivery with proprietary eClinical technology. EDC, RTSM, CTMS, eTMF, IRB, and drug safety under one partner.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
Coral Gables
Corporate office
3119 Ponce de Leon, Coral Gables, FL 33134, United States
Additional offices
London, United Kingdom · Bengaluru, India
Sector focus
Frequently asked questions
What services and technology does Sitero offer?
Sitero provides full-service clinical operations, drug safety and pharmacovigilance, IRB ethical review, and biosafety/IBC services. Its proprietary Mentor eClinical suite includes EDC, RTSM, CTMS/eTMF, eConsent, and site and participant payments. The firm bundles these to offer an integrated trial-delivery model that it claims can accelerate study startup.
Is Sitero a clinical research organization (CRO) or a software vendor?
Sitero operates as a hybrid, combining a CRO-like clinical services arm with a proprietary eClinical technology platform. Unlike traditional CROs that may rely on third-party software, Sitero delivers both the services and the Mentor technology stack under one contract.
Where does Sitero have physical offices?
Sitero lists corporate headquarters in Coral Gables, Florida, with additional offices in London, United Kingdom, and Bengaluru, India. These locations support its global clinical and technology operations.
What is Sitero’s IRB service model?
Sitero offers institutional review board (IRB) ethical review services with a flat-fee pricing model, which the firm contrasts with competitor structures. The IRB is supported by a team of ethicists and integrated with its broader clinical compliance capabilities.
Does Sitero serve sponsors of all sizes?
Sitero was founded to offer accessible services to pharmaceutical, biotech, and institutional research organizations of all sizes. Its client base exceeds 200 organizations globally, ranging from small biotechs to larger pharma companies, as described on its website.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: